Nirvana Life Sciences Inc.
NIRVX
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.00K | 1.30K | 1.30K | 1.90K | 400.00 |
| Total Receivables | 14.00K | 13.40K | 12.10K | 12.10K | 13.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.00K | 14.70K | 13.30K | 14.10K | 14.10K |
|
|
|||||
| Total Current Assets | 15.00K | 14.70K | 13.30K | 14.10K | 14.10K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.00K | 14.70K | 13.30K | 14.10K | 14.10K |
|
|
|||||
| Total Accounts Payable | 126.20K | 120.30K | 143.00K | 184.20K | 81.60K |
| Total Accrued Expenses | 243.20K | 205.00K | 176.00K | 830.60K | 769.40K |
| Short-term Debt | 104.80K | 97.90K | 75.70K | 71.30K | 67.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 5.00K | -- |
| Total Other Current Liabilities | -- | -- | -- | 5.00K | -- |
| Total Current Liabilities | 474.20K | 423.20K | 394.60K | 1.09M | 918.20K |
|
|
|||||
| Total Current Liabilities | 474.20K | 423.20K | 394.60K | 1.09M | 918.20K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 104.80K | 97.90K | 75.70K | 71.30K | 67.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 63.60K | 29.70K | 0.00 | -- | 18.20K |
| Total Liabilities | 537.80K | 452.80K | 394.60K | 1.09M | 936.40K |
|
|
|||||
| Common Stock & APIC | 5.81M | 5.62M | 5.70M | 5.01M | 4.78M |
| Retained Earnings | -6.75M | -6.45M | -6.49M | -6.50M | -6.09M |
| Treasury Stock & Other | 423.90K | 399.00K | 415.20K | 415.90K | 386.60K |
| Total Common Equity | -519.00K | -434.30K | -377.70K | -1.07M | -918.20K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -519.00K | -434.30K | -377.70K | -1.07M | -918.20K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.90K | -3.90K | -3.60K | -3.60K | -4.00K |
| Total Equity | -522.90K | -438.20K | -381.30K | -1.08M | -922.30K |
|
|
|||||